Corbus Pharmaceuticals Holdings Inc

XNAS:CRBP 4:00:00 PM EDT

8.86

-1.74 (-16.38%)

7:59:19 PM EDT: $9.00 +0.14 (+1.52%)

Market Cap (Intraday)	171.35M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.67 Million
Adjusted EPS	-$1.21

See more estimates

10-Day MA	$10.58
50-Day MA	$9.77
200-Day MA	$9.26

See more pivots

Corbus Pharmaceuticals Holdings Inc Stock, XNAS:CRBP

500 River Ridge Drive, 2nd floor, Norwood, Massachusetts 02062

United States of America

Phone: +1.617.963.0100

Number of Employees: 28

http://www.corbuspharma.com

Description

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFÃ?Å? expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.